Impact of diabetes mellitus on long-term clinical outcomes of patients on chronic hemodialysis after percutaneous coronary intervention

Journal of Interventional Cardiology

Volumn 25, Issue 2, 2012, Pages 147-155

  Sardi, Gabriel L ^a   Maluenda, Gabriel ^a   Torguson, Rebecca ^a   Xue, Zhenyi ^a   Suddath, William O ^a   Kent, Kenneth M ^a   Lindsay, Joseph ^a   Satler, Lowell F ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CORONARY ARTERY CIRCUMFLEX BRANCH; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE CLASSIFICATION; DRUG ELUTING STENT; FALSE ANEURYSM; FEMALE; FISTULA; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEALTH STATUS; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMATOMA; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; RIGHT CORONARY ARTERY; SAPHENOUS VEIN GRAFT; STROKE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DRUG-ELUTING STENTS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETREATMENT;

EID: 84859721653     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2011.00682.x     Document Type: Article

References (33)

1. US Renal Data System, USRDS 2009 annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2009.
2. US Renal Data System, USRDS 2010 annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2010.
3. Best PJ, Lennon R, Ting HH, et al,. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002; 39: 1113-1119.
4. Hage FG, Venkataraman R, Zoghbi GJ, et al,. The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol 2009; 53: 2129-2140.
5. Herzog CA, Ma JZ, Collins AJ,. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998; 339: 799-805.
6. Le Feuvre C, Borentain M, Beygui F, et al,. Comparison of short- and long-term outcomes of coronary angioplasty in patients with and without diabetes mellitus and with and without hemodialysis. Am J Cardiol 2003; 92: 721-725.
7. Rubenstein MH, Harrell LC, Sheynberg BV, et al,. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 2000; 102: 2966-2972.
8. Szczech LA, Best PJ, Crowley E, et al,. Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation. Circulation 2002; 105: 2253-2258.
9. Charytan D, Mauri L, Agarwal A, et al,. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. Am Heart J 2006; 152: 558-564.
10. Chertow GM, Normand SL, Silva LR, et al,. Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the cooperative cardiovascular project. Am J Kidney Dis 2000; 35: 1044-1051.
11. Hassani SE, Chu WW, Wolfram RM, et al,. Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J Invasive Cardiol 2006; 18: 273-277.
12. Bonello L, De Labriolle A, Roy P, et al,. Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome. Am J Cardiol 2008; 102: 535-540.
13. Aronson D, Bloomgarden Z, Rayfield EJ,. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 1996; 27: 528-535.
14. Takasawa Y, Iijima R, Shiba M, et al,. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention. J Cardiol 2010; 55: 391-396.
15. Aronson D, Edelman ER,. Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting. Rev Endocr Metab Disord 2010; 11: 75-86.
16. Le Feuvre C, Dambrin G, Helft G, et al,. Clinical outcome following coronary angioplasty in dialysis patients: A case-control study in the era of coronary stenting. Heart 2001; 85: 556-560.
17. Azar RR, Prpic R, Ho KK, et al,. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 2000; 86: 485-489.
18. Best PJ, Berger PB, Davis BR, et al,. Impact of mild or moderate chronic kidney disease on the frequency of restenosis: Results from the PRESTO trial. J Am Coll Cardiol 2004; 44: 1786-1791.
19. Szczech LA, Reddan DN, Owen WF, et al,. Differential survival after coronary revascularization procedures among patients with renal insufficiency. Kidney Int 2001; 60: 292-299.
20. Wright RS, Reeder GS, Herzog CA, et al,. Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann Intern Med 2002; 137: 563-570.
21. Herzog CA, Ma JZ, Collins AJ,. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 2002; 106: 2207-2211.
22. Nikolsky E, Mehran R, Turcot D, et al,. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 2004; 94: 300-305.
23. Halkin A, Selzer F, Marroquin O, et al,. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. J Invasive Cardiol 2006; 18: 577-583.
24. Ashrith G, Elayda MA, Wilson JM,. Revascularization options in patients with chronic kidney disease. Tex Heart Inst J 2010; 37: 9-18.
25. Jeong YH, Hong MK, Lee CW, et al,. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation. Int J Cardiol 2008; 125: 36-40.
26. Blackman DJ, Pinto R, Ross JR, et al,. Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention. Am Heart J 2006; 151: 146-152.
27. Gruberg L, Weissman NJ, Pichard AD, et al,. Impact of renal function on morbidity and mortality after percutaneous aortocoronary saphenous vein graft intervention. Am Heart J 2003; 145: 529-534.
28. Nikolsky E, Aymong ED, Halkin A, et al,. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 2004; 44: 547-553.
29. Voeltz MD, Patel AD, Feit F, et al,. Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention. Am J Cardiol 2007; 99: 1513-1517.
30. Maluenda G, Lemesle G, Collins SD, et al,. The clinical significance of hematocrit values before and after percutaneous coronary intervention. Am Heart J 2009; 158: 1024-1030.
31. Luscher TF, Creager MA, Beckman JA, et al,. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part II. Circulation 2003; 108: 1655-1661.
32. Carrozza JP, Jr., Kuntz RE, Fishman RF, et al,. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med 1993; 118: 344-349.
33. Corpus RA, George PB, House JA, et al,. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 2004; 43: 8-14.